HealthEquity (HQY) Tops Q4 EPS by 2c, Offers Guidance

Go back to HealthEquity (HQY) Tops Q4 EPS by 2c, Offers Guidance

HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2023 Financial Results

March 21, 2023 4:01 PM EDT

Highlights of the fiscal year include:

Revenue of $861.7 million, an increase of 14% compared to $756.6 million in FY22.Net loss of $26.1 million, compared to $44.3 million in FY22, with non-GAAP net income of $114.5 million, compared to $110.2 million in FY22.Net loss per diluted share of $0.31, compared to $0.53 in FY22, with non-GAAP net income per diluted share of $1.36, compared to $1.33 in FY22.Adjusted EBITDA of $272.3 million, an increase of 15% compared to $236.0 million in FY22.8.0 million HSAs, an increase of 11% compared to FY22.Total HSA Assets of $22.1 billion, an increase of 13%... More